Metropolitan Life Insurance Company (MetLife)’s Sensient Technologies SXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,198
Closed -$152K 1876
2024
Q1
$152K Sell
2,198
-227
-9% -$14.7K 0.01% 828
2023
Q4
$160K Hold
2,425
0.01% 847
2023
Q3
$142K Buy
2,425
+123
+5% +$7.75K 0.01% 841
2023
Q2
$164K Buy
2,302
+62
+3% +$4.6K 0.01% 765
2023
Q1
$171K Sell
2,240
-340
-13% -$25.3K 0.01% 726
2022
Q4
$188K Buy
2,580
+83
+3% +$5.95K 0.01% 742
2022
Q3
$173K Hold
2,497
0.01% 728
2022
Q2
$201K Sell
2,497
-143
-5% -$11.9K 0.01% 690
2022
Q1
$222K Sell
2,640
-14,617
-85% -$1.23M 0.01% 769
2021
Q4
$1.73M Sell
17,257
-620
-3% -$60.3K 0.02% 619
2021
Q3
$1.63M Sell
17,877
-1,225
-6% -$107K 0.02% 623
2021
Q2
$1.65M Buy
19,102
+713
+4% +$60.4K 0.02% 643
2021
Q1
$1.43M Sell
18,389
-120
-0.6% -$9.22K 0.02% 721
2020
Q4
$1.37M Sell
18,509
-894
-5% -$62.4K 0.02% 678
2020
Q3
$1.12M Sell
19,403
-635
-3% -$35K 0.02% 677
2020
Q2
$1.05M Sell
20,038
-2,894
-13% -$137K 0.02% 716
2020
Q1
$998K Sell
22,932
-531
-2% -$29.3K 0.02% 680
2019
Q4
$1.55M Sell
23,463
-1,078
-4% -$69K 0.02% 676
2019
Q3
$1.68M Sell
24,541
-287
-1% -$19.6K 0.03% 580
2019
Q2
$1.82M Buy
24,828
+9
+0% +$636 0.03% 565
2019
Q1
$1.68M Buy
24,819
+1
+0% +$63 0.03% 579
2018
Q4
$1.39M Buy
24,818
+30
+0.1% +$1.96K 0.03% 617
2018
Q3
$1.9M Sell
24,788
-38
-0.2% -$2.71K 0.03% 558
2018
Q2
$1.78M Buy
24,826
+456
+2% +$31.6K 0.03% 589
2018
Q1
$1.72M Sell
24,370
-640
-3% -$46.1K 0.02% 624
2017
Q4
$1.83M Sell
25,010
-45,022
-64% -$3.43M 0.02% 600
2017
Q3
$5.39M Sell
70,032
-760
-1% -$57.6K 0.03% 543
2017
Q2
$5.7M Buy
70,792
+567
+0.8% +$45.8K 0.04% 491
2017
Q1
$5.57M Sell
70,225
-272
-0.4% -$21.4K 0.04% 524
2016
Q4
$5.54M Sell
70,497
-2,146
-3% -$164K 0.04% 503
2016
Q3
$5.51M Sell
72,643
-970
-1% -$71.2K 0.04% 472
2016
Q2
$5.23M Buy
73,613
+1,341
+2% +$90.8K 0.04% 500
2016
Q1
$4.59M Buy
72,272
+812
+1% +$47.8K 0.04% 554
2015
Q4
$4.49M Buy
71,460
+376
+0.5% +$24.3K 0.03% 551
2015
Q3
$4.36M Sell
71,084
-905
-1% -$59.5K 0.03% 570
2015
Q2
$4.92M Sell
71,989
-6,500
-8% -$441K 0.03% 556
2015
Q1
$5.41M Buy
78,489
+931
+1% +$58.1K 0.04% 488
2014
Q4
$4.68M Buy
77,558
+305
+0.4% +$17.5K 0.03% 572
2014
Q3
$4.04M Sell
77,253
-730
-0.9% -$39.8K 0.03% 615
2014
Q2
$4.34M Sell
77,983
-3,472
-4% -$189K 0.03% 610
2014
Q1
$4.59M Buy
81,455
+727
+0.9% +$37.4K 0.03% 572
2013
Q4
$3.92M Buy
80,728
+1,959
+2% +$97.6K 0.03% 631
2013
Q3
$3.77M Buy
78,769
+503
+0.6% +$22K 0.03% 615
2013
Q2
$3.17M Buy
+78,266
New +$3.1M 0.03% 664

Other funds holding SXT

Metropolitan Life Insurance Company (MetLife)'s SXT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Sensient Technologies (SXT) in Q2 2024, closing a stake of 2,198 shares — an estimated $152K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SXT in Q2 2013 and held it in 44 quarters. The position peaked at $5.7M in Q2 2017. 249 funds tracked by Wall St. Rank hold SXT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Sensient Technologies position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,198 Sensient Technologies shares in Q2 2024, an estimated $152K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Sensient Technologies in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Sensient Technologies position peaked at $5.7M in Q2 2017.
  • 249 funds tracked by Wall St. Rank held Sensient Technologies as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.